485 related articles for article (PubMed ID: 27955711)
21. Hepatic safety of maraviroc in HIV-1-infected patients with hepatitis C and/or B co-infection. The Maraviroc Cohort Spanish Group.
Crespo M; Navarro J; Moreno S; Sanz J; Márquez M; Zamora J; Ocampo A; Iribaren JA; Rivero A; Llibre JM
Enferm Infecc Microbiol Clin; 2017 Oct; 35(8):493-498. PubMed ID: 27061975
[TBL] [Abstract][Full Text] [Related]
22. Correlation of transient elastography with APRI and FIB-4 in a cohort of patients with congenital bleeding disorders and HCV or HIV/HCV coinfection.
Vidovic N; Lochowsky RS; Goldmann G; Rockstroh J; Wasmuth JC; Spengler U; Sauerbruch T; Lammert F; Oldenburg J; Grünhage F
Haemophilia; 2010 Sep; 16(5):778-85. PubMed ID: 20331759
[TBL] [Abstract][Full Text] [Related]
23. More improvement than progression of liver fibrosis following antiretroviral therapy in a longitudinal cohort of HIV-infected patients with or without HBV and HCV co-infections.
Ding Y; Duan S; Ye R; Yang Y; Yao S; Wang J; Cao D; Liu X; Lu L; Jia M; Wu Z; He N
J Viral Hepat; 2017 May; 24(5):412-420. PubMed ID: 27925409
[TBL] [Abstract][Full Text] [Related]
24. Genotypic distribution and hepatic fibrosis among HIV/HCV co-infected individuals in Southern China: a retrospective cross-sectional study.
Zhou K; Hu F; Wang C; Xu M; Lan Y; Morano JP; Lemon SM; Tucker JD; Cai W
BMC Infect Dis; 2015 Sep; 15():401. PubMed ID: 26424404
[TBL] [Abstract][Full Text] [Related]
25. Assessment of liver fibrosis and associated risk factors in HIV-infected individuals using transient elastography and serum biomarkers.
Vermehren J; Vermehren A; Mueller A; Carlebach A; Lutz T; Gute P; Knecht G; Sarrazin C; Friedrich-Rust M; Forestier N; Poynard T; Zeuzem S; Herrmann E; Hofmann WP
BMC Gastroenterol; 2012 Mar; 12():27. PubMed ID: 22453133
[TBL] [Abstract][Full Text] [Related]
26. Changes in biomarkers of liver disease during successful combination antiretroviral therapy in HIV-HCV-coinfected individuals.
Rohrbach J; Stickel F; Schmid P; Thormann W; Kovari H; Scherrer A; Günthard HF; Vuichard D; Cavassini M; Ambrosioni J; Bernasconi E; Furrer H; Rauch A;
Antivir Ther; 2014; 19(2):149-59. PubMed ID: 24036684
[TBL] [Abstract][Full Text] [Related]
27. Liver stiffness and fibrosis-4 alone better predict liver events compared with aspartate aminotransferase to platelet ratio index in a cohort of human immunodeficiency virus and hepatitis C virus co-infected patients from ANRS CO13 HEPAVIH cohort.
Chalouni M; Sogni P; Miailhes P; Lacombe K; Poizot-Martin I; Chas J; Vittecoq D; Neau D; Aumaitre H; Alric L; Piroth L; Bouchaud O; Katlama C; Morlat P; Lascoux-Combe C; Gervais A; Naqvi A; Rosenthal E; Garipuy D; Barange K; Esterle L; Salmon D; Wittkop L;
Eur J Gastroenterol Hepatol; 2019 Nov; 31(11):1387-1396. PubMed ID: 31033848
[TBL] [Abstract][Full Text] [Related]
28. Does fibrosis really regress in HIV/hepatitis C virus co-infected patients after treatment with direct antiviral agents?
Rial-Crestelo D; Sepúlveda MA; González-Gasca FJ; Geijo-Martínez P; Martínez-Alfaro E; Barberá JR; Yzusqui M; Casallo S; García M; Hornero CM; Espinosa-Gimeno A; Torralba M
AIDS; 2020 Mar; 34(3):427-432. PubMed ID: 31996593
[TBL] [Abstract][Full Text] [Related]
29. The Burden of Hepatitis C Infection-Related Liver Fibrosis in the United States.
Klevens RM; Canary L; Huang X; Denniston MM; Yeo AE; Pesano RL; Ward JW; Holmberg S
Clin Infect Dis; 2016 Oct; 63(8):1049-55. PubMed ID: 27506688
[TBL] [Abstract][Full Text] [Related]
30. Responder Interferon λ Genotypes Are Associated With Higher Risk of Liver Fibrosis in HIV-Hepatitis C Virus Coinfection.
Moqueet N; Cooper C; Gill J; Hull M; Platt RW; Klein MB;
J Infect Dis; 2016 Jul; 214(1):80-6. PubMed ID: 26984148
[TBL] [Abstract][Full Text] [Related]
31. Antiretroviral treatment interruption leads to progression of liver fibrosis in HIV-hepatitis C virus co-infection.
Thorpe J; Saeed S; Moodie EE; Klein MB;
AIDS; 2011 Apr; 25(7):967-75. PubMed ID: 21330904
[TBL] [Abstract][Full Text] [Related]
32. Time on antiretroviral therapy is a protective factor for liver fibrosis in HIV and hepatitis C virus (HCV) co-infected patients.
Tural C; Fuster D; Tor J; Ojanguren I; Sirera G; Ballesteros A; Lasanta JA; Planas R; Rey-Joly C; Clotet B
J Viral Hepat; 2003 Mar; 10(2):118-25. PubMed ID: 12614468
[TBL] [Abstract][Full Text] [Related]
33. IL15 polymorphism is associated with advanced fibrosis, inflammation-related biomarkers and virological response in human immunodeficiency virus/hepatitis C virus coinfection.
Jiménez-Sousa MA; Berenguer J; Rallón N; Pineda-Tenor D; Aldamiz-Echevarria T; Soriano V; García-Álvarez M; Vazquez-Morón S; Restrepo C; Carrero A; Benito JM; Resino S
Liver Int; 2016 Sep; 36(9):1258-66. PubMed ID: 26836972
[TBL] [Abstract][Full Text] [Related]
34. Evaluating liver fibrosis progression and the impact of antiretroviral therapy in HIV and hepatitis C coinfection using a noninvasive marker.
Al-Mohri H; Murphy T; Lu Y; Lalonde RG; Klein MB
J Acquir Immune Defic Syndr; 2007 Apr; 44(4):463-9. PubMed ID: 17211282
[TBL] [Abstract][Full Text] [Related]
35. Correlates of spontaneous clearance of hepatitis C virus in a Danish human immunodeficiency virus type 1 cohort.
Clausen LN; Weis N; Schønning K; Fenger M; Krarup H; Bukh J; Benfield T
Scand J Infect Dis; 2011 Oct; 43(10):798-803. PubMed ID: 21728744
[TBL] [Abstract][Full Text] [Related]
36. Do serum markers of liver fibrosis vary by HCV infection in patients with alcohol use disorder?
Sanvisens A; Muñoz A; Bolao F; Zuluaga P; Farré M; Jarrin I; Tor J; Muga R
Drug Alcohol Depend; 2018 Jul; 188():180-186. PubMed ID: 29778771
[TBL] [Abstract][Full Text] [Related]
37. HIV virological rebounds but not blips predict liver fibrosis progression in antiretroviral-treated HIV/hepatitis C virus-coinfected patients.
Cooper C; Rollet-Kurhajec KC; Young J; Vasquez C; Tyndall M; Gill J; Pick N; Walmsley S; Klein MB;
HIV Med; 2015 Jan; 16(1):24-31. PubMed ID: 24837567
[TBL] [Abstract][Full Text] [Related]
38. Clinical and virological characteristics of hepatitis B or C virus co-infection with HIV in Indonesian patients.
Anggorowati N; Yano Y; Heriyanto DS; Rinonce HT; Utsumi T; Mulya DP; Subronto YW; Hayashi Y
J Med Virol; 2012 Jun; 84(6):857-65. PubMed ID: 22499006
[TBL] [Abstract][Full Text] [Related]
39. Is antiretroviral therapy causing long-term liver damage? A comparative analysis of HIV-mono-infected and HIV/hepatitis C co-infected cohorts.
Moodie EE; Pant Pai N; Klein MB
PLoS One; 2009; 4(2):e4517. PubMed ID: 19223976
[TBL] [Abstract][Full Text] [Related]
40. Brief Report: HIV/HBV Coinfection is a Significant Risk Factor for Liver Fibrosis in Tanzanian HIV-Infected Adults.
Hawkins C; Christian B; Fabian E; Macha I; Gawile C; Mpangala S; Ulenga N; Thio CL; Ammerman LR; Mugusi F; Fawzi W; Green R; Murphy R
J Acquir Immune Defic Syndr; 2017 Nov; 76(3):298-302. PubMed ID: 29016448
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
